Stepan Company (SCL) AI Stock Analysis

NYSE: SCLAI research summary: business, growth, valuation, analysts, bull and bear case.

SCL AI stock analysis summary

AI Research

Stepan Company (SCL) produces specialty and intermediate chemicals across its Surfactants, Polymers, and Specialty Products segments. Over the trailing twelve months, the company generated $2.43B in revenue with diluted EPS of -$0.12, while quarterly revenue grew 15.0% year-over-year in the quarter ended June 30, 2026. The stock closed at $62.03 with a forward P/E of 17.5x and offers an annual forward dividend of $1.58.

Market cap
$1.41B
Revenue (TTM)
$2.43B
P/E
—
fwd 17.5x
1Y return
38.3%
S&P 500 16.8%
Avg. target
$85.00
37.0% vs last close

Bull case

  • Quarterly revenue grew 15.0% year-over-year in the quarter ended June 30, 2026, alongside quarterly earnings growth of 101.6%.
  • The consensus mean price target of $85.00 represents 37.0% upside over the last close of $62.03.
  • Stepan has paid consecutive dividends for 42 years, supported by an annualized 5-year dividend growth rate of 6.5%.

Bear case

  • Trailing twelve months EPS was -$0.12, reflecting a TTM profit margin of -0.1%.
  • Net debt of $593.6M remains substantial relative to cash and short-term investments of $113.7M as of June 30, 2026.
  • The stock's 5-year return of -42.6% significantly lags the S&P 500 return of 83.0%.

What Stepan does

Founded in 1932, Stepan Company manufactures specialty and intermediate chemicals across three core segments: Surfactants, Polymers, and Specialty Products. Its Surfactants segment produces chemicals used in consumer and industrial cleaning products like detergents, shampoos, and disinfectants, as well as agricultural and industrial applications. The Polymers segment supplies polyurethane polyols for rigid foam insulation, foundational materials for coatings, adhesives, sealants, elastomers, polyester resins, and phthalic anhydride. Its Specialty Products segment provides flavors, emulsifiers, and solubilizers for food, nutritional supplements, and pharmaceuticals. Stepan operates globally, serving markets across the United States, Europe, and Latin America.

Growth and profitability

Stepan Company grew revenue from $2.35B in FY2021 to a peak of $2.77B in FY2022, before sales declined 16.1% to $2.33B in FY2023 and fell 6.3% to $2.18B in FY2024. In FY2025, revenue rebounded 7.0% to $2.33B, delivering a 5-year revenue CAGR of 4.5% from FY2020 to FY2025. Annual net income fell from $137.8M in FY2021 and $147.2M in FY2022 to $46.9M in FY2025, with net margin narrowing from 5.9% to 2.0%. For the trailing twelve months, revenue reached $2.43B with an operating margin of 6.2% and EPS of -$0.12. In the latest quarter ended June 30, 2026, quarterly revenue grew 15.0% year-over-year, and quarterly earnings grew 101.6%.

SCL income statement →

Balance sheet and cash flow

As of June 30, 2026, Stepan Company held $113.7M in cash and short-term investments against total debt of $707.3M, resulting in net debt of $593.6M. Total assets stood at $2.39B and shareholders' equity was $1.21B, reflecting a debt-to-equity ratio of 0.58 and a current ratio of 1.15. In FY2025, the company generated operating cash flow of $147.9M and free cash flow of $25.4M. Capital expenditures totaled $122.5M, while dividends paid used $35.0M and share issuance generated $104,000.

SCL balance sheet →

Valuation and performance

Stepan Company holds a market cap of $1.41B and an enterprise value of $2.04B. The stock trades at a forward P/E of 17.5x, above the 13.4x median of its US-listed Basic Materials peers. Its price-to-sales ratio of 0.6x and EV-to-EBITDA of 9.0x compare to sector peer medians of 1.8x and 10.5x, respectively. The stock carries a PEG ratio of 1.75 and a price-to-book ratio of 1.2x. Over the past year, SCL returned 38.3%, outpacing the S&P 500's 16.8% return, though its 5-year return of -42.6% trails the S&P 500's 83.0% gain.

SCL key metrics →

SCL dividend

Stepan Company pays a quarterly dividend with an annual forward dividend of $1.58, representing a dividend yield of 2.55% as of October 16, 2026. The company has paid consecutive dividends for 42 years and delivered an annualized 5-year dividend growth rate of 6.5%. Its payout ratio is 75.6%, and the most recent ex-dividend date was September 1, 2026.

SCL dividend history →

What analysts expect

Wall Street coverage includes 1 Strong Buy rating, with 0 Buy, 0 Hold, 0 Sell, and 0 Strong Sell ratings. The mean price target is $85.00, representing 37.0% upside versus the last close of $62.03. For the fiscal year ending December 31, 2026, analysts estimate revenue of $2.53B and EPS of $2.69, representing 47.8% EPS growth. Over the last four quarters, the company beat EPS estimates 2 times. The next earnings date is October 28, 2026.

SCL forecast and price target →

Key risks and what to watch

  • The company carries total debt of $707.3M with a debt-to-equity ratio of 0.58.
  • Free cash flow was -$85.5M in FY2023 before recovering to $39.3M in FY2024 and $25.4M in FY2025.
  • The dividend payout ratio stands at 75.6%, which leaves less flexibility if net income drops below the FY2025 level of $46.9M.
  • Operating margin contracted from 7.5% in FY2022 to 3.0% in FY2025, showing ongoing sensitivity to cost pressures.

AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer

About this SCL AI stock analysis

This page is an AI-written research summary of Stepan Company (SCL). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: SCL income statement, SCL balance sheet, SCL key metrics, SCL analyst forecast, SCL chart. See the SCL stock overview for the latest quote and news.

SCL AI stock analysis FAQ

What is Stepan Company's dividend yield and payment record?

Stepan Company offers an annual forward dividend of $1.58, translating to a dividend yield of 2.55% as of October 16, 2026. The company has paid consecutive dividends for 42 years with a 5-year annualized dividend growth rate of 6.5%.

When does Stepan Company report its next quarterly earnings?

The company's next earnings date is scheduled for October 28, 2026. Over the last four quarters, Stepan has beaten analyst EPS estimates 2 times.

What are analysts' expectations for SCL's full-year earnings?

For the fiscal year ending December 31, 2026, analysts estimate EPS of $2.69, representing 47.8% growth, on estimated revenue of $2.53B. For the following fiscal year, analysts project EPS of $3.69 on revenue of $2.68B.

How does Stepan Company's valuation compare to its peers?

Stepan trades at a forward P/E of 17.5x, higher than the median of 13.4x for its US-listed Basic Materials peers. However, its price-to-sales ratio of 0.6x and EV-to-EBITDA of 9.0x are below peer medians of 1.8x and 10.5x.

More Basic Materials AI stock analysis